Incidence of Churg-Strauss syndrome in asthma drug users: A population-based perspective

Journal of Rheumatology

Volumn 32, Issue 6, 2005, Pages 1076-1080

  Harrold, Leslie R ^a,b,j   Andrade, Susan E ^a,b   Go, Alan S ^b,c,d   Buist, A Sonia ^b,e   Eisner, Mark ^b,c,d   Vollmer, William M ^f   Chan, K Arnold ^b,g   Frazier, E Ann ^f   Weller, Peter F ^h   Wechsler, Michael E ^h   Yood, Robert A ^a,b   Davis, Kourtney J ⁱ   Platt, Richard ^b,h  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HMO Research Network Center for Education and Research in Therapeutics   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f Research Network Center for Education and Research in Therapeutics

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ GLAXOSMITHKLINE   (United States)

^j UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

more..

Author keywords

Administrative data; Automated data; Churg Strauss syndrome; Incidence

Indexed keywords

ADRENALIN; BECLOMETASONE; BITOLTEROL; BUDESONIDE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE; ISOETARINE; ISOPRENALINE; LEVALBUTEROL; MONTELUKAST; NEDOCROMIL; ORCIPRENALINE; PIRBUTEROL; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE DERIVATIVE; TRIAMCINOLONE; ZAFIRLUKAST; ZILEUTON;

ADULT; AGED; AMBULATORY CARE; ASTHMA; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; FEMALE; HOSPITAL PATIENT; HUMAN; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MONONEUROPATHY; PARANASAL SINUS; POLYNEUROPATHY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; CHURG-STRAUSS SYNDROME; DATABASES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 20444493937     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Watts RA, Scott DGI. Epidemiology of the vasculitides. Curr Opin Rheum 2003;15:11-6.
2. Watts RA, Carruthers DM, Scott DGI. Epidemiology of systemic vasculitis: Changing the incidence or definition? Semin Arthritis Rheum 1995;25:28-35.
3. Watts RA, Lane SE, Bentham G, Scott DGI. Epidemiology of systemic vasculitis: A ten-year study in the United Kingdom. Arthritis Rheum 2000;43:414-9.
4. Weller PR, Plaut M, Taggart V, Trontell A. The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 2001;108:175-83.
5. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998;279:455-7.
6. Knoell DL, Lucas J, Allen JN. Churg-Strauss syndrome associated with zafirlukast. Chest 1998;114:332-4.
7. Frosi A, Foresi A, Bozzoni M, Ubbiali A, Vezzoli F. Churg-Strauss syndrome and antiasthma therapy [letter]. Lancet 1999;353:1102.
8. Green RL, Vayonis AG. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet 1999;353:725-6.
9. Wechsler M, Drazen JM. Churg-Strauss syndrome. Lancet 1999;353:1970-1.
10. Wechsler ME, Drazen JM. Zafirlukast and Churg-Strauss syndrome. Chest 1999;116:266-7.
11. Wechsler ME, Finn D, Gunawardena D, et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000;117:708-13.
12. Martin RM, Wilton LV, Mann RD. Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf 1999;8:179-89.
13. Platt R, Davis R, Finkelstein J, et al. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research in Therapeutics. Pharmacoepidemiol Drug Saf 2001;10:373-7.
14. Harrold LR, Andrade SE, Eisner M, et al. Identification of patients with Churg-Strauss syndrome using automated data. Pharmacoepidemiol Drug Saf 2004;13:661-7.
15. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
16. Anonymous. From the Centers for Disease Control and Prevention. Self-reported asthma prevalence and control among adults-United States, 2001. JAMA 2003;289:2639-40.
17. Snyder L, Blanc PD, Katz PP, Yelin EH, Eisner MD. Leukotriene modifier use and asthma severity: How is a new medication being used by adults with asthma? Arch Intern Med 2004;164:617-22.
18. Loughlin JE, Cole JA, Rothman KJ, Johnson ES. Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients. Ann Allergy Asthma Immunol 2002;88:319-25.
19. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez P, Llorca J. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference Definitions. Arthritis Rheum 2003;49:388-93.
20. Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology criteria in the diagnosis of vasculitis. Ann Intern Med 1998;129:345-52.
21. Hunder GG. The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med 1998;129:417-8.
22. Watts RA, Lane SE, Scott DGI, et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001;60:1156-7.